{
    "clinical_study": {
        "@rank": "95858", 
        "acronym": "PRE-MUSICAL", 
        "arm_group": [
            {
                "arm_group_label": "Music therapy", 
                "arm_group_type": "Experimental", 
                "description": "\"U\" sequence: the musical sequence lasts 20 minutes and is made up of several phases that progressively induce a relaxed state in the patient. The phase of maximum relaxation is followed by a stimulating phase."
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Interview with an occupational activity (such as discussion of personal pictures or news) with the caregiver in charge of music therapy sessions with the same period."
            }
        ], 
        "brief_summary": {
            "textblock": "The primary purpose of the protocol is to demonstrate that the use of music therapy may make\n      it possible to discontinue at least one of neuroleptic treatment in patients with AD or\n      related symptoms complicated by behavioral disorders such as agitation and aggressiveness\n      evaluated using the Neuropsychiatric Inventory (NPI).\n\n      The study hypothesis is that music therapy may have a positive impact on patients with AD\n      complicated by behavioral disorders by reducing the intensity of oppositional behaviour and\n      aggressiveness and allowing a diminution of neuroleptic treatment."
        }, 
        "brief_title": "Music Therapy in Alzheimer's Disease", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Alzheimer's Type Dementia With Disruptive Behaviour", 
        "condition_browse": {
            "mesh_term": [
                "Alzheimer Disease", 
                "Dementia"
            ]
        }, 
        "detailed_description": {
            "textblock": "A technique of receptive music therapy to induce relaxation has been developed in the\n      university hospital of Montpellier: the \"U\" sequence. The musical sequence lasts 20 minutes\n      and is made up of several phases that progressively induce a relaxed state in the patient.\n      This effect is obtained by modulating the rhythm of the music, the orchestral formation,\n      frequencies and volume. The phase of maximum relaxation is followed by a stimulating phase.\n      These musical sequences have been specially designed by the music publishers Music Care\u00a9."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects of either sex aged 65 years and over, living in an institution for the\n             dependent elderly for at least 3 months\n\n          -  Subjects with Alzheimer-type dementia (DSM-IV and  National Institute of Neurological\n             and Communicative Disorders and Stroke - Alzheimer's Disease and Related Disorders\n             Association (NINCDS-ADRDA) criteria)or related symptoms\n\n          -  If treated, Treated for at least 6 months with a stable dose of cholinesterase\n             inhibitor or memantine\n\n          -  Mini-Mental State Examination (MMSE) score between 5 and 20\n\n          -  Patients with disruptive behaviour (at least one disruptive item on the NPI:\n             oppositional behaviour/aggressiveness/agitation, aberrant motor behaviour, with a\n             severity score grater than or equal to 4) and treated with at least one neuroleptic\n             whose dose which could not be decreased because of persistence of the behavioural\n             problems for at least 15 days.\n\n        Exclusion Criteria:\n\n          -  Decompensated physical disease\n\n          -  Inability to give informed consent\n\n          -  Lack of health insurance coverage\n\n          -  Non-corrected hearing impairment\n\n          -  treatment ongoing with two or more neuroleptics"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02020356", 
            "org_study_id": "12 385 02", 
            "secondary_id": "AOL 2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Music therapy", 
                "description": "\"U\" sequence: the musical sequence lasts 20 minutes and is made up of several phases that progressively induce a relaxed state in the patient. The phase of maximum relaxation is followed by a stimulating phase.", 
                "intervention_name": "Music therapy", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Interview with an occupational activity (such as discussion of personal pictures or news) with the caregiver in charge of music therapy sessions with the same period.", 
                "intervention_name": "Placebo", 
                "intervention_type": "Behavioral"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Antipsychotic Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Alzheimer's disease", 
            "Disruptive behaviours", 
            "Neuroleptics", 
            "Music therapy"
        ], 
        "lastchanged_date": "December 18, 2013", 
        "location": [
            {
                "contact": {
                    "email": "rolland.y@chu-toulouse.fr", 
                    "last_name": "Yves ROLLAND, PhD", 
                    "phone": "0534557607", 
                    "phone_ext": "33"
                }, 
                "facility": {
                    "address": {
                        "city": "Toulouse", 
                        "country": "France", 
                        "state": "Midi-Pyrenees", 
                        "zip": "31059"
                    }, 
                    "name": "University Hospital Toulouse"
                }, 
                "investigator": {
                    "last_name": "Yves ROLLAND, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "r-feugas@chic-cm.fr", 
                    "last_name": "FEUGAS , MD", 
                    "phone": "0618379153", 
                    "phone_ext": "33"
                }, 
                "facility": {
                    "address": {
                        "city": "Castres", 
                        "country": "France", 
                        "state": "Tarn", 
                        "zip": "81100"
                    }, 
                    "name": "EHPAD La Villegiale"
                }, 
                "investigator": {
                    "last_name": "FEUGAS, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "agirbressolle@orange.fr", 
                    "last_name": "HALWANI , MD", 
                    "phone": "0563722040", 
                    "phone_ext": "33"
                }, 
                "facility": {
                    "address": {
                        "city": "Castres", 
                        "country": "France", 
                        "state": "Tarn", 
                        "zip": "81100"
                    }, 
                    "name": "Residence Christian Bressole"
                }, 
                "investigator": {
                    "last_name": "HALWANI, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "patrice.rascol@wanadoo.fr", 
                    "last_name": "Patrice RASCOL, MD", 
                    "phone": "0563502251", 
                    "phone_ext": "33"
                }, 
                "facility": {
                    "address": {
                        "city": "Labruguiere", 
                        "country": "France", 
                        "state": "Tarn", 
                        "zip": "81290"
                    }, 
                    "name": "EHPAD L'Oustal d'en Thibaud"
                }, 
                "investigator": {
                    "last_name": "Patrice RASCOL, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "elisabeth.delga@wanadoo.fr", 
                    "last_name": "Elisabeth DELGA, MD", 
                    "phone": "0607026966", 
                    "phone_ext": "33"
                }, 
                "facility": {
                    "address": {
                        "city": "Lautrec", 
                        "country": "France", 
                        "state": "Tarn", 
                        "zip": "81440"
                    }, 
                    "name": "EHPAD Les Quietudes"
                }, 
                "investigator": {
                    "last_name": "Elisabeth DELGA, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Impact of Music Therapy on Prescription of Neuroleptics in Alzheimer's Disease ou Related Symptoms Associated With Disruptive Behaviours.", 
        "other_outcome": {
            "description": "Proportions of patients in the two groups who discontinued neuroleptics, Scores on the Cohen-Mansfield scale, Dose of neuroleptics", 
            "measure": "Music therapy session's effects", 
            "safety_issue": "No", 
            "time_frame": "4 weeks after completion of music therapy sessions"
        }, 
        "overall_contact": {
            "email": "arbus.c@chu-toulouse.fr", 
            "last_name": "Christophe ARBUS, MD", 
            "phone": "0534557510", 
            "phone_ext": "33"
        }, 
        "overall_contact_backup": {
            "email": "peyrot.c@chu-toulouse.fr", 
            "last_name": "Caroline PEYROT, CRA", 
            "phone": "0561778486", 
            "phone_ext": "33"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Benefit obtained in terms of the reduction in neuroleptic dose", 
            "measure": "Neuroloeptic reduction dose", 
            "safety_issue": "No", 
            "time_frame": "during 2 months"
        }, 
        "reference": [
            {
                "PMID": "15920712", 
                "citation": "Aalten P, de Vugt ME, Jaspers N, Jolles J, Verhey FR. The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. Int J Geriatr Psychiatry. 2005 Jun;20(6):523-30."
            }, 
            {
                "PMID": "8433315", 
                "citation": "Aldridge D. Music and Alzheimer's disease--assessment and therapy: discussion paper. J R Soc Med. 1993 Feb;86(2):93-5."
            }, 
            {
                "PMID": "15791352", 
                "citation": "Benoit M, Robert PH, Staccini P, Brocker P, Guerin O, Lechowski L, Vellas B; REAL.FR Group. One-year longitudinal evaluation of neuropsychiatric symptoms in Alzheimer's disease. The REAL.FR Study. J Nutr Health Aging. 2005;9(2):95-9."
            }, 
            {
                "PMID": "2715584", 
                "citation": "Cohen-Mansfield J, Marx MS, Rosenthal AS. A description of agitation in a nursing home. J Gerontol. 1989 May;44(3):M77-84."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02020356"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Score on the Cohen-Mansfield scale, Overall NPI score, Quality of life in Alzheimer's disease scale (QOL-AD)", 
            "measure": "Durability of treatment effect", 
            "safety_issue": "No", 
            "time_frame": "1, 2 and 3 months"
        }, 
        "source": "University Hospital, Toulouse", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Toulouse", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}